Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress

HIV and antiretroviral (ART) exposure in utero may have deleterious effects on the infant, but uncertainty still exists. The objective of this study was to evaluate aspects of mitochondrial DNA (mtDNA) content, mitochondrial function and oxidative stress simultaneously in placenta, umbilical cord blood and infant blood in HIV/ART‐exposed infants compared with uninfected controls.

[1]  G. Aldrovandi,et al.  Antiretroviral Exposure and Lymphocyte mtDNA Content Among Uninfected Infants of HIV-1-Infected Women , 2009, Pediatrics.

[2]  K. Anastos,et al.  Oxidant stress in HIV-infected women from the Women's Interagency HIV Study , 2009, Antiviral therapy.

[3]  U. Jeschke,et al.  Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy , 2008, Antiviral therapy.

[4]  F. O. Pettersen,et al.  Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment. , 2008, The Journal of infectious diseases.

[5]  P. Harrigan,et al.  Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants. , 2008, The Journal of infectious diseases.

[6]  Minhee Kang,et al.  Increased mtDNA Levels Without Change in Mitochondrial Enzymes in Peripheral Blood Mononuclear Cells of Infants Born to HIV-Infected Mothers on Antiretroviral Therapy , 2008, HIV clinical trials.

[7]  S. Spector,et al.  Impact of Nucleoside Reverse Transcriptase Inhibitors on Mitochondria in Human Immunodeficiency Virus Type 1-Infected Children Receiving Highly Active Antiretroviral Therapy , 2007, Antimicrobial Agents and Chemotherapy.

[8]  M. Hughes,et al.  In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children , 2007, AIDS.

[9]  R. Ness,et al.  Genotoxicity assessed by the comet and GPA assays following in vitro exposure of human lymphoblastoid cells (H9) or perinatal exposure of mother–child pairs to AZT or AZT‐3TC , 2007, Environmental and molecular mutagenesis.

[10]  O. Olivero.  Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors , 2007, Environmental and molecular mutagenesis.

[11]  K. Witt,et al.  Mitochondrial toxicity in hearts of CD‐1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination , 2007, Environmental and molecular mutagenesis.

[12]  K. Nagashima,et al.  Morphological and molecular course of mitochondrial pathology in cultured human cells exposed long‐term to Zidovudine , 2007, Environmental and molecular mutagenesis.

[13]  K. Nagashima,et al.  Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor‐induced mitochondrial toxicity , 2007, Environmental and molecular mutagenesis.

[14]  J. O’Neill,et al.  Plasma and cellular markers of 3′‐azido‐3′‐dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIs , 2007, Environmental and molecular mutagenesis.

[15]  D. L. Cook,et al.  Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD‐1 mice to single agents or drug combinations , 2007, Environmental and molecular mutagenesis.

[16]  K. Nagashima,et al.  Cardiac mitochondrial compromise in 1-yr-old Erythrocebus patas monkeys perinatally- exposed to nucleoside reverse transcriptase inhibitors , 2007, Cardiovascular Toxicology.

[17]  F. Dabis,et al.  Serum Lactate Levels in Infants Exposed Peripartum to Antiretroviral Agents to Prevent Mother-to-Child Transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 Study, Abidjan, Ivory Coast , 2006, Pediatrics.

[18]  P. Rustin,et al.  Mitochondrial dysfunction following perinatal exposure to nucleoside analogues , 2006, AIDS.

[19]  D. Mbanya,et al.  The effect of different combination therapies on oxidative stress markers in HIV infected patients in cameroon , 2006, AIDS research and therapy.

[20]  L. Sandvik,et al.  Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV‐1‐infected treatment‐naïve patients , 2006, HIV medicine.

[21]  P. Reiss,et al.  Infection with HIV-1 induces a decrease in mtDNA. , 2005, The Journal of infectious diseases.

[22]  G. Moyle.  Mechanisms of HIV and Nucleoside Reverse Transcriptase Inhibitor Injury to Mitochondria , 2005, Antiviral therapy.

[23]  R. Cutler,et al.  Novel markers of oxidative stress in actively progressive HIV dementia , 2004, Journal of Neuroimmunology.

[24]  M. Poirier,et al.  Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs. , 2004, Toxicology and Applied Pharmacology.

[25]  Ò. Miró,et al.  Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  K. Nagashima,et al.  Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir , 2004, AIDS.

[27]  J. Morrow,et al.  Lipid Oxidative Markers Are Significantly Increased in Lipoatrophy But Not in Sustained Asymptomatic Hyperlactatemia , 2003, Journal of acquired immune deficiency syndromes.

[28]  D. Money,et al.  Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy , 2003, The Pediatric infectious disease journal.

[29]  P. Rustin,et al.  Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort , 2003, AIDS.

[30]  Vernon E Walker,et al.  Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. , 2003, Journal of acquired immune deficiency syndromes.

[31]  S. Mallal,et al.  Assessment of precision and concordance of quantitative mitochondrial DNA assays: a collaborative international quality assurance study. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[32]  M. Gerschenson,et al.  Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. , 2003, Journal of acquired immune deficiency syndromes.

[33]  U. Walker,et al.  Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors , 2002, AIDS.

[34]  L. Mofenson,et al.  Combination Antiretroviral Strategies for the Treatment of Pregnant HIV‐1‐Infected Women and Prevention of Perinatal HIV‐1 Transmission , 2002, Journal of acquired immune deficiency syndromes.

[35]  C. Giaquinto,et al.  Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission. , 2001, AIDS.

[36]  M. Lampe,et al.  Lack of Evidence of Mitochondrial Dysfunction in the Offspring of HIV‐Infected Women: Retrospective Review of Perinatal Exposure to Antiretroviral Drugs in the Perinatal AIDS Collaborative Transmission Study , 2000, Annals of the New York Academy of Sciences.

[37]  C. Chougnet,et al.  Incorporation of Zidovudine into Cord Blood DNA of Infants and Peripheral Blood DNA of Their HIV‐1‐Positive Mothers , 2000, Annals of the New York Academy of Sciences.

[38]  K. Nagashima,et al.  Genotoxic and Functional Consequences of Transplacental Zidovudine Exposure in Fetal Monkey Brain Mitochondria , 2000, Journal of acquired immune deficiency syndromes.

[39]  K. Nagashima,et al.  Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine. , 2000, AIDS research and human retroviruses.

[40]  T. Patterson,et al.  Incorporation of 3'-azido-3'-deoxythymidine (AZT) into fetal DNA and fetal tissue distribution of drug after infusion of pregnant late-term rhesus macaques with a human-equivalent AZT dose. , 1999, Journal of acquired immune deficiency syndromes.

[41]  L. Anderson,et al.  Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-3'-deoxythymidine in mice. , 1999, Toxicology and applied pharmacology.

[42]  P. Rustin,et al.  Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues , 1999, The Lancet.

[43]  R. Tarone,et al.  Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. , 1999, AIDS.

[44]  S. Tüzgen,et al.  The effect of epidural cooling on lipid peroxidation after experimental spinal cord injury , 1998, Spinal Cord.

[45]  L. Anderson,et al.  Transplacental effects of 3'-azido-2',3'-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys. , 1997, Journal of the National Cancer Institute.

[46]  R. Capaldi,et al.  Mammalian cytochrome-c oxidase: characterization of enzyme and immunological detection of subunits in tissue extracts and whole cells. , 1995, Methods in enzymology.

[47]  C. Geny,et al.  Zidovudine myopathy: A distinctive disorder associated with mitochondrial dysfunction , 1991, Annals of neurology.